The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness.

Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep (2011) 1.35

Reliability of a single objective measure in assessing sleepiness. Sleep (2012) 1.17

MSLT in primary insomnia: stability and relation to nocturnal sleep. Sleep (2011) 1.13

Sleep disorders and associated medical comorbidities in active duty military personnel. Sleep (2013) 1.09

Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency. JAMA Neurol (2013) 1.02

Sleep apnea-related risk of motor vehicle accidents is reduced by continuous positive airway pressure: Swedish Traffic Accident Registry data. Sleep (2015) 0.94

Can the MSLT be a useful tool to assess motor vehicle crash risk in sleepy drivers? Sleep (2010) 0.93

Natural history of excessive daytime sleepiness: role of obesity, weight loss, depression, and sleep propensity. Sleep (2015) 0.92

Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS (2011) 0.89

Obstructive sleep apnea syndrome; a neglected cause of traffic collision among Iranian public transport drivers. J Inj Violence Res (2013) 0.88

Common sleep disorders increase risk of motor vehicle crashes and adverse health outcomes in firefighters. J Clin Sleep Med (2015) 0.87

Animal models of sleep disorders. Comp Med (2013) 0.82

Investigation of obstructive sleep apnoea syndrome prevalence among long-distance drivers from Zonguldak, Turkey. Multidiscip Respir Med (2013) 0.78

Association between pupillometric sleepiness measures and sleep latency derived by MSLT in clinically sleepy patients. Environ Health Prev Med (2013) 0.78

Enhancements to the multiple sleep latency test. Nat Sci Sleep (2016) 0.78

Car Crashes and Central Disorders of Hypersomnolence: A French Study. PLoS One (2015) 0.78

Identifying periods of drowsy driving using EEG. Ann Adv Automot Med (2013) 0.76

Baseline sleep dysfunction among matriculating interns. J Grad Med Educ (2012) 0.75

The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep (2003) 9.71

Extended work shifts and the risk of motor vehicle crashes among interns. N Engl J Med (2005) 8.73

Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep (2005) 5.66

Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res (2003) 4.79

Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest (1993) 4.18

Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep (2004) 3.78

Neurobehavioral performance of residents after heavy night call vs after alcohol ingestion. JAMA (2005) 3.64

Sleep deprivation and vigilant attention. Ann N Y Acad Sci (2008) 3.60

Sleepiness, driving, and motor vehicle crashes. Council on Scientific Affairs, American Medical Association. JAMA (1998) 3.10

Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep (2004) 2.90

Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol (1978) 2.79

Sleep loss and fatigue in residency training: a reappraisal. JAMA (2002) 2.55

Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep (1997) 2.48

Characteristics of crashes attributed to the driver having fallen asleep. Accid Anal Prev (1995) 2.25

The clinical use of the MSLT and MWT. Sleep (2005) 2.14

Medical and socio-professional impact of insomnia. Sleep (2002) 2.05

Sleep apnea and commercial motor vehicle operators: Statement from the joint task force of the American College of Chest Physicians, the American College of Occupational and Environmental Medicine, and the National Sleep Foundation. Chest (2006) 1.99

Intra-individual daily and yearly variability in actigraphically recorded sleep measures: the CARDIA study. Sleep (2007) 1.96

Sleep and reported daytime sleepiness in normal subjects: the Sleep Heart Health Study. Sleep (2004) 1.93

Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest (1995) 1.75

Sleep habits and accident risk among truck drivers: a cross-sectional study in Argentina. Sleep (2005) 1.67

Fatigue, sleep restriction and driving performance. Accid Anal Prev (2005) 1.60

The Maintenance of Wakefulness Test and driving simulator performance. Sleep (2005) 1.58

A new questionnaire to detect sleep disorders. Sleep Med (2002) 1.53

Effects of rapid versus slow accumulation of eight hours of sleep loss. Psychophysiology (2001) 1.37

Predictors of objective sleep tendency in the general population. Sleep (2003) 1.24

Modafinil improves alertness, vigilance, and executive function during simulated night shifts. Sleep (2004) 1.19

Ethanol and sleep loss: a "dose" comparison of impairing effects. Sleep (2003) 1.17

Daytime driving simulation performance and sleepiness in obstructive sleep apnoea patients. Accid Anal Prev (2007) 1.17

Sleepy driver near-misses may predict accident risks. Sleep (2007) 1.15

Circadian variation of sleep tendency in elderly and young adult subjects. Sleep (1982) 1.10

Level of sleepiness and total sleep time following various time in bed conditions. Sleep (1993) 1.08

Objective measures of sleepiness and wakefulness: application to the real world? J Clin Neurophysiol (2006) 1.03

A National Sleep Foundation's conference summary: the National Summit to Prevent Drowsy Driving and a new call to action. Ind Health (2005) 1.01

Subjective sleepiness ratings (Epworth sleepiness scale) do not reflect the same parameter of sleepiness as objective sleepiness (maintenance of wakefulness test) in patients with narcolepsy. Clin Neurophysiol (1999) 0.98

Caffeine reversal of ethanol effects on the multiple sleep latency test, memory, and psychomotor performance. Neuropsychopharmacology (2002) 0.96

Maintenance of wakefulness test as a predictor of driving performance in patients with untreated obstructive sleep apnea. Sleep (2007) 0.95

Maintenance of Wakefulness Test, obstructive sleep apnea syndrome, and driving risk. Ann Neurol (2008) 0.93

Narcolepsy and excessive daytime sleepiness: diagnostic considerations, epidemiology, and comorbidities. J Clin Psychiatry (2007) 0.92

Sleepiness and ethanol effects on simulated driving. Alcohol Clin Exp Res (1994) 0.91

Awareness of sleepiness and ability to predict sleep onset: can drivers avoid falling asleep at the wheel? Sleep Med (2007) 0.89

Subjective sleepiness and accident risk avoiding the ecological fallacy. J Sleep Res (2006) 0.88

Test-retest reliability of the MSLT. Sleep (1988) 0.86

Risk-taking behavior: effects of ethanol, caffeine, and basal sleepiness. Sleep (2004) 0.85

Psychometric evaluation of daytime sleepiness and nocturnal sleep onset scales in a representative community sample. Biol Psychiatry (1999) 0.82

Comparative sensitivity of a simulated driving task to self-report, physiological, and other performance measures during prolonged wakefulness. J Psychosom Res (2005) 0.78

Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet (2006) 13.16

Gene expression during the life cycle of Drosophila melanogaster. Science (2002) 11.36

Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet (2006) 7.90

Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry (2008) 6.73

The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr (2013) 6.18

A genome-wide association study of alcohol dependence. Proc Natl Acad Sci U S A (2010) 4.94

Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA (2012) 4.71

ABC transporters: the power to change. Nat Rev Mol Cell Biol (2009) 4.48

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep (2003) 4.29

History of the development of sleep medicine in the United States. J Clin Sleep Med (2005) 4.22

Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res (2008) 4.17

Cerebral air embolism following removal of central venous catheter. Mil Med (2009) 4.04

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91

Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep (2004) 3.78

Developmental control of blood cell migration by the Drosophila VEGF pathway. Cell (2002) 3.12

Sleep loss and REM sleep loss are hyperalgesic. Sleep (2006) 3.03

Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res (2002) 2.99

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry (2006) 2.86

Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet (2009) 2.86

Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis (2002) 2.80

The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res (2009) 2.63

The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res (2006) 2.60

Unwrapping glial biology: Gcm target genes regulating glial development, diversification, and function. Neuron (2003) 2.54

Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med (2005) 2.51

Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res (2002) 2.48

Incidence of drug problems in young adults exposed to trauma and posttraumatic stress disorder: do early life experiences and predispositions matter? Arch Gen Psychiatry (2007) 2.19

Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep (2007) 2.19

Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15

Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic study. Arch Gen Psychiatry (2004) 2.13

Epidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender difference. Pediatrics (2006) 2.06

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep (2008) 2.04

The impact of early behavior disturbances on academic achievement in high school. Pediatrics (2009) 2.03

Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry (2012) 2.02

Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet (2008) 1.95

Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. Cancer Epidemiol Biomarkers Prev (2008) 1.87

The association between obesity and short sleep duration: a population-based study. J Clin Sleep Med (2005) 1.87

Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem (2002) 1.86

The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep (2003) 1.86

Vulnerability to stress-related sleep disturbance and hyperarousal. Sleep (2004) 1.84

The high-affinity E. coli methionine ABC transporter: structure and allosteric regulation. Science (2008) 1.83

Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology (2012) 1.83

Microbial ferric iron reductases. FEMS Microbiol Rev (2003) 1.82

The use of stimulants to modify performance during sleep loss: a review by the sleep deprivation and Stimulant Task Force of the American Academy of Sleep Medicine. Sleep (2005) 1.81

DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5. Addiction (2012) 1.81

Insomnia and the performance of US workers: results from the America insomnia survey. Sleep (2011) 1.77

Wilderness Medical Society practice guidelines for the prevention and treatment of frostbite. Wilderness Environ Med (2011) 1.77

Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev (2001) 1.75

Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73

Using difficulty resuming sleep to define nocturnal awakenings. Sleep Med (2010) 1.73

Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone (2003) 1.72

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep (2007) 1.72

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet (2008) 1.72

The scoring of arousal in sleep: reliability, validity, and alternatives. J Clin Sleep Med (2007) 1.71

Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: collaborative study. J AOAC Int (2003) 1.66

Stability of psychiatric outcomes of low birth weight: a longitudinal investigation. Arch Gen Psychiatry (2008) 1.64

The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res (2011) 1.62

A comparison of the effects of 2 types of massage and usual care on chronic low back pain: a randomized, controlled trial. Ann Intern Med (2011) 1.58

Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety (2003) 1.54

Prenatal smoking exposure, low birth weight, and disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry (2007) 1.54

Efficacy and safety of zolpidem extended release in elderly primary insomnia patients. Am J Geriatr Psychiatry (2008) 1.51

Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol (2005) 1.48

Late-preterm birth and its association with cognitive and socioemotional outcomes at 6 years of age. Pediatrics (2010) 1.46

NMR R1 rho rotating-frame relaxation with weak radio frequency fields. J Am Chem Soc (2004) 1.46

Patient-reported outcomes in insomnia: development of a conceptual framework and endpoint model. Behav Sleep Med (2013) 1.43

Race differences in nicotine dependence in the Collaborative Genetic study of Nicotine Dependence (COGEND). Nicotine Tob Res (2008) 1.42

Caffeine: sleep and daytime sleepiness. Sleep Med Rev (2007) 1.41

Insomnia: pathophysiology and implications for treatment. Sleep Med Rev (2006) 1.41

Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch Gen Psychiatry (2004) 1.41

Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. Mayo Clin Proc (2009) 1.38

Posttraumatic stress disorder and suicide attempts in a community sample of urban american young adults. Arch Gen Psychiatry (2009) 1.38

Sleep during titration predicts continuous positive airway pressure compliance. Sleep (2003) 1.37

Sleep and pain: interaction of two vital functions. Semin Neurol (2005) 1.37

Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep (2011) 1.35

Comorbidity of depression with levels of smoking: an exploration of the shared familial risk hypothesis. Nicotine Tob Res (2004) 1.31

Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin (2004) 1.29

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin (2006) 1.28

Adverse events after screening and follow-up colonoscopy. Cancer Causes Control (2011) 1.27

Toward quantitative interpretation of methyl side-chain dynamics from NMR by molecular dynamics simulations. J Am Chem Soc (2007) 1.26

Sleep hygiene practices in a population-based sample of insomniacs. Sleep (2005) 1.26

Immortalization of mouse germ line stem cells. Stem Cells (2005) 1.25

Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). Int J Gen Med (2011) 1.24

Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft. J Am Chem Soc (2008) 1.24

Saliva cortisol in posttraumatic stress disorder: a community epidemiologic study. Biol Psychiatry (2004) 1.20

Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep (2011) 1.19

Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med (2007) 1.17

Ethanol and sleep loss: a "dose" comparison of impairing effects. Sleep (2003) 1.17

The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep (2006) 1.17

Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatrics (2006) 1.16

Childhood antecedents of exposure to traumatic events and posttraumatic stress disorder. Am J Psychiatry (2007) 1.16

Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration. J Clin Pharmacol (2013) 1.16